Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.French pharmaceutical group Sanofi-Aventis has reported adjusted net income of E1.9 billion for the third quarter of 2008, an increase of 1.9%, compared to E1.85 billion posted in the third quarter of 2007. Adjusted net income excluding selected items was E1.92 billion, up 2.1% from E1.88 billion in the third quarter of 2007.
Subscribe to our email newsletter
The company reported net sales of E6.85 billion for the third quarter of 2008, an increase of 5.5% on a comparable basis. On a reported basis, the company posted a decrease of 2.4% in net sales, compared to E7.02 billion posted in the third quarter of 2007.
Adjusted earnings per share (EPS) for the third quarter of 2008 were E1.45, an increase of 5.8%, compared to E1.37 posted in the third quarter of 2007. Adjusted EPS excluding selected items were E1.47, an increase of 5%, compared to E1.40 for the corresponding period of 2007.
For the first nine months of 2008, Sanofi-Aventis recorded net sales of E20.48 billion, a decrease of 3.1%, compared with E21.14 billion in the same period in 2007.
For the first nine months of 2008, the company reported adjusted net income of E5.36 billion, a decrease of 5.2%, compared with E5.65 billion in the corresponding period of 2007. Adjusted net income excluding selected items was E5.56 billion, an increase of 0.5%, compared to E5.53 billion for the first nine months of 2007.
Adjusted earnings per share for the first nine months of 2008 were E4.09, a decrease of 2.2%, compared to E4.20 posted in the same period of 2007. Adjusted EPS excluding selected items were E4.24, an increase of 3.4%, compared to E4.10 for the first nine months of 2007.